跳至主要内容
临床试验/CTRI/2023/11/059857
CTRI/2023/11/059857已完成4 期

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of GUT RESET Capsules in Alleviating the Gastro-Esophageal Reflux (GER)-Related Symptoms. ? - NI

Herbal Creations (A Unit of Kumaon Exports Pvt. Ltd.)0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Apparently healthy adults of any gender 18 - 60 years of age, willing to provide consent affected by symptoms of GER.
  • 2. History of GER-related symptoms for at least 1 month prior to study inclusion and otherwise healthy
  • 3. Not participated in any other interventional trials in the last 1 month before trial recruitment
  • 4. Willing to discontinue medications like H2 Receptor antagonists, Antacids, Pro-kinetics, and supplements that have been prescribed for the GER related symptoms and not on any of these agents in the last 10 days before randomization.
  • 5. Presence of symptoms of at least 2 days in the week preceding randomization

排除标准

  • 1. Presence of any of the following red flag symptoms such as Iron deficiency anemia, weight loss, persistent vomiting, GI bleed, epigastric mass
  • 2. Women of reproductive age who are pregnant / lactating / not willing for adequate contraception.
  • 3. History of allergy to any medications including alternate system of medications
  • 4. History of uncontrolled diabetes (Random Blood Sugar > 200mg%)
  • 5. Inability to follow the protocol or expressed inability to complete all follow-ups.
  • 6. Abnormalities in the liver function tests (defined as total bilirubin >1mg% or SGOT / SGPT > 3 times the upper limit of normal)
  • 7. Abnormal renal function test (Creatinine > 1.4mg%)
  • 8. Congestive cardiac failure and other medical conditions which the investigator feels will affect the pharmacokinetic parameters of the study drug.
  • 9. History of erosive esophagitis, Barrett’s esophagus, tumoral pathologies, atypical pathology without heartburn and ulcer
  • 10. Presence of HIV, HbsAG or HCV positive and any other medical/ surgical condition the investigator feels may cause harm to the participant.

研究者

发起方
Herbal Creations (A Unit of Kumaon Exports Pvt. Ltd.)

相似试验